MLchartDataset catalogue

autologous gene-modified PD-1-positive T lymphocytes Sc610

Term · Oncology and biomedicine · MLC-T-ONC-011631

A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous gene-modified PD-1-positive T lymphocytes Sc610 bind to tumor cells expressing the antigen for the as of yet undisclosed receptor, which may result in specific cytotoxic T-lymphocyte (CTL)-mediated tumor cell killing.

Table 1. Record
IdentifierMLC-T-ONC-011631
FieldOncology and biomedicine
Synonymsautologous gene-modified PD-1-positive T cells Sc610
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011631",
  "term": "autologous gene-modified PD-1-positive T lymphocytes Sc610",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous gene-modified PD-1-positive T lymphocytes Sc610 bind to tumor cells expressing the antigen for the as of yet undisclosed receptor, which may result in specific cytotoxic T-lymphocyte (CTL)-mediated tumor cell killing.",
  "synonyms": [
    "autologous gene-modified PD-1-positive T cells Sc610"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-gene-modified-pd-1-positive-t-lymphocytes-sc610/"
}

Record 2,966 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.